Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared to previously published studies, this is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnsworth, Paul, Ward, David, Reddy, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514141/
https://www.ncbi.nlm.nih.gov/pubmed/23210606
http://dx.doi.org/10.1186/2162-3619-1-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514141/
https://www.ncbi.nlm.nih.gov/pubmed/23210606
http://dx.doi.org/10.1186/2162-3619-1-29

Ejemplares similares